V2
General Information
DCTPep ID DCTPep00113
Peptide Name V2
Sequence CVKVSVKVGSGVKVSVKVC
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Membrane-targeted
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
THP-1 | Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia | IC50=5660 µM | CellTiter 96 AQueous One Solution assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis=589 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep00113
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys1<--->Cys19
N-terminal Modification Acetylization
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C83H153N23O23S2
Absent amino acids ADEFHILMNPQRTWY
Theoretical pI 9.70
Acidic residues 0
Basic residues 4
Polar residues 7
Molecular weight (Average) 1905.39
Molecular weight (Monoisotopic) 1904.1
Common amino acids V
Net charge 4
Instability index (II) -22.9
Aliphatic index 122.11
Grand average of hydropathicity (GRAVY) 1.042
Half Life
1.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 125
Abs 0.1% (=1 g/l) 0.066, assuming all pairs of Cys residues form cystines
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 15328096
Title De novo design of potent antimicrobial peptides
Doi 10.1128/AAC.48.9.3349-3357.2004
Year 2004
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available